A 3D microfibrous scaffold for long-term human pluripotent stem cell self-renewal under chemically defined conditions

Biomaterials

Volumn 33, Issue 8, 2012, Pages 2419-2430

  Lu, Hong Fang ^a   Narayanan, Karthikeyan ^a   Lim, Sze Xian ^a   Gao, Shujun ^a   Leong, Meng Fatt ^a   Wan, Andrew C A ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Cell culture; Cell encapsulation; Cell proliferation; Scaffold; Stem cell

Indexed keywords

CELL ENCAPSULATIONS; CELL LOADING; CELL MARKERS; CELL VIABILITY; CLINICAL APPLICATION; CRYO-PRESERVATION; CULTURE SYSTEMS; ENCAPSULATED CELL; IN-SITU; IN-VITRO; IN-VIVO; MICRO-FIBER; MICROFIBERS; MICROFIBROUS; MULTICELLULAR STRUCTURE; PLURIPOTENT STEM CELLS; UNIQUE FEATURES;

ANIMAL CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; MOLECULAR BIOLOGY; SCAFFOLDS; STEM CELLS; THREE DIMENSIONAL;

SCAFFOLDS (BIOLOGY);

BIOLOGICAL MARKER; GENOMIC DNA; MOLECULAR SCAFFOLD;

ARTICLE; BIOENGINEERING; CELL DENSITY; CELL ENCAPSULATION; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; DEACETYLATION; ECTODERM; EMBRYO; EMBRYO DEVELOPMENT; ENDODERM; FIBER; FLOW CYTOMETRY; GERM LAYER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KARYOTYPE; MESODERM; MICROARRAY ANALYSIS; MICROENVIRONMENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; STEM CELL TRANSPLANTATION; SURFACE PROPERTY; THREE DIMENSIONAL IMAGING; THREE DIMENSIONAL MICROFIBER SYSTEM;

ALGINATES; ANIMALS; CELL AGGREGATION; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CELLS, IMMOBILIZED; CHITIN; COLLAGEN; CRYOPRESERVATION; DRUG COMBINATIONS; EMBRYONIC STEM CELLS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; LAMININ; MICE; MICE, SCID; PHENOTYPE; PLURIPOTENT STEM CELLS; PROTEOGLYCANS; TERATOMA; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 84855846248     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.077     Document Type: Article

References (44)

1. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells invivo. Nat Biotechnol 2008, 26:443-452.
2. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006, 24:1392-1401.
3. Mao G.H., Chen G.A., Bai H.Y., Song T.R., Wang Y.X. The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cells. Biomaterials 2009, 30:1706-1714.
4. Zhang S.C., Wernig M., Duncan I.D., Brustle O., Thomson J.A. Invitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001, 19:1129-1133.
5. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001, 19:1134-1140.
6. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. JClin Invest 2001, 108:407-414.
7. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453:322-329.
8. Ryan E.A., Lakey J.R., Paty B.W., Imes S., Korbutt G.S., Kneteman N.M., et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51:2148-2157.
9. Atala A., Bauer S.B., Soker S., Yoo J.J., Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367:1241-1246.
10. Mason C., Dunhill P. Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors. Regen Med 2009, 4:153-157.
11. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
12. Ludwig T.E., Bergendahl V., Levenstein M.E., Yu J., Probasco M.D., Thomson J.A. Feeder-independent culture of human embryonic stem cells. Nat Methods 2006, 3:637-646.
13. Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R., Frane J.L., et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006, 24:185-187.
14. Klim J.R., Li L., Wrighton P.J., Piekarczyk M.S., Kiessling L.L. Adefined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods 2010, 7:989-994.
15. Mei Y., Saha K., Bogatyrev S.R., Yang J., Hook A.L., Kalcioglu Z.I., et al. Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater 2010, 9:768-778.
16. Rodin S., Domogatskaya A., Strom S., Hansson E.M., Chien K.R., Inzunza J., et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 2010, 28:611-615.
17. Villa-Diaz L.G., Nandivada H., Ding J., Nogueira-de-Souza N.C., Krebsbach P.H., O'Shea K.S., et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol 2010, 28:581-583.
18. Melkoumian Z., Weber J.L., Weber D.M., Fadeev A.G., Zhou Y., Dolley-Sonneville P., et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 2010, 28:606-610.
19. Irwin E.F., Gupta R., Dashti D.C., Healy K.E. Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells. Biomaterials 2011, 32:6912-6919.
20. Dellatore S.M., Garcia A.S., Miller W.M. Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol 2008, 19:534-540.
21. Lutolf M.P., Gilbert P.M., Blau H.M. Designing materials to direct stem-cell fate. Nature 2009, 462:433-441.
22. Hoffman L.M., Carpenter M.K. Characterization and culture of human embryonic stem cells. Nat Biotechnol 2005, 23:699-708.
23. Dawson E., Mapili G., Erickson K., Taqvi S., Roy K. Biomaterials for stem cell differentiation. Adv Drug Deliv Rev 2008, 60:215-228.
24. Wang X., Ye K. Three-dimensional differentiation of embryonic stem cells into islet-like insulin-producing clusters. Tissue Eng Part A 2009, 15:1941-1952.
25. Chayosumrit M., Tuch B., Sidhu K. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials 2010, 31:505-514.
26. Li Z., Leung M., Hopper R., Ellenbogen R., Zhang M. Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds. Biomaterials 2010, 31:404-412.
27. Gerecht S., Burdick J.A., Ferreira L.S., Townsend S.A., Langer R., Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 2007, 104:11298-11303.
28. Levenberg S., Huang N.F., Lavik E., Rogers A.B., Itskovitz-Eldor J., Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 2003, 100:12741-12746.
29. Kraehenbuehl T.P., Langer R., Ferreira L.S. Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods 2011, 8:731-736.
30. Yim E.K., Wan A.C., Le Visage C., Liao I.C., Leong K.W. Proliferation and differentiation of human mesenchymal stem cell encapsulated in polyelectrolyte complexation fibrous scaffold. Biomaterials 2006, 27:6111-6122.
31. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
32. Narayanan K., Leck K.J., Gao S., Wan A.C. Three-dimensional reconstituted extracellular matrix scaffolds for tissue engineering. Biomaterials 2009, 30:4309-4317.
33. Tai B.C., Du C., Gao S., Wan A.C., Ying J.Y. The use of a polyelectrolyte fibrous scaffold to deliver differentiated hMSCs to the liver. Biomaterials 2010, 31:48-57.
34. Cowan C.A., Klimanskaya I., McMahon J., Atienza J., Witmyer J., Zucker J.P., et al. Derivation of embryonic stem-cell lines from human blastocysts. NEngl J Med 2004, 350:1353-1356.
35. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., et al. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
36. Ng S.L., Narayanan K., Gao S., Wan A.C. Lineage restricted progenitors for the repopulation of decellularized heart. Biomaterials 2011, 32:7571-7580.
37. Lu H., Koshkin V., Allister E.M., Gyulkhandanyan A.V., Wheeler M.B. Molecular and metabolic evidence for mitochondrial defects associated with beta-cell dysfunction in a mouse model of type 2 diabetes. Diabetes 2010, 59:448-459.
38. Wan A.C., Yim E.K., Liao I.C., Le Visage C., Leong K.W. Encapsulation of biologics in self-assembled fibers as biostructural units for tissue engineering. JBiomed Mater Res A 2004, 71:586-595.
39. Amit M., Carpenter M.K., Inokuma M.S., Chiu C.P., Harris C.P., Waknitz M.A., et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000, 227:271-278.
40. Leung H.W., Chen A., Choo A.B., Reuveny S., Oh S.K. Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods 2011, 17:165-172.
41. Toh Y.C., Voldman J. Fluid shear stress primes mouse embryonic stem cells for differentiation in a self-renewing environment via heparan sulfate proteoglycans transduction. FASEB J 2011, 25:1208-1217.
42. Harrison N.J., Baker D., Andrews P.W. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int J Androl 2007, 30:275-281.
43. Maitra A., Arking D.E., Shivapurkar N., Ikeda M., Stastny V., Kassauei K., et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005, 37:1099-1103.
44. Zweigerdt R., Olmer R., Singh H., Haverich A., Martin U. Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc 2011, 6:689-690.